Financhill
Back

Denali Therapeutics Stock Price Chart

  • The current trend is relatively stagnant and DNLI is experiencing slight selling pressure.

Denali Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 26.63 Sell
20-day SMA: 26.94 Sell
50-day SMA: 27.28 Sell
200-day SMA: 21.72 Buy
8-day EMA: 26.73 Sell
20-day EMA: 27.05 Sell
50-day EMA: 26.66 Sell
200-day EMA: 23.64 Buy

Denali Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 43.08 Sell
Chaikin Money Flow: -171845 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.24 - 28.5) Sell
Bollinger Bands (100): (22 - 27.78) Buy

Denali Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Denali Therapeutics Stock

Is Denali Therapeutics Stock a Buy?

DNLI Technical Analysis vs Fundamental Analysis

Sell
47
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics a Buy or a Sell?

Denali Therapeutics Stock Info

Market Cap:
3.72B
Price in USD:
25.96
Share Volume:
552.69K

Denali Therapeutics 52-Week Range

52-Week High:
32.13
52-Week Low:
14.56
Sell
47
Denali Therapeutics (DNLI) is a Sell

Denali Therapeutics Share Price Forecast

Is Denali Therapeutics Stock a Buy?

  • Denali Therapeutics share price is 25.96 while DNLI 8-day exponential moving average is 26.73, which is a Sell signal.
  • The stock price of DNLI is 25.96 while Denali Therapeutics 20-day EMA is 27.05, which makes it a Sell.
  • Denali Therapeutics 50-day exponential moving average is 26.66 while DNLI share price is 25.96, making it a Sell technically.
  • DNLI stock price is 25.96 and Denali Therapeutics 200-day simple moving average is 23.64, creating a Buy signal.

Fundamental Analysis of Denali Therapeutics

Is Denali Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.55 per share, and a decrease next year of $0.02 per share.

Technical Analysis of Denali Therapeutics

Should I short Denali Therapeutics stock?

* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.